Skip to Content

The New Treatment Landscape of Multiple Myeloma in the Perspective of New Front-line Therapies

The treatment of Multiple Myeloma is changing these years with the approval of new drugs and new combinations of therapies. In this MEDtalk, Claudio Cerchione, M.D., Ph.D., Dirigente Medico Ematologia, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori,” gives his perspective of the treatment now and in the future.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top